Cargando…

A Novel Automatic Quantification Protocol for Biomarkers of Tauopathies in the Hippocampus and Entorhinal Cortex of Post-Mortem Samples Using an Extended Semi-Siamese U-Net

SIMPLE SUMMARY: Tauopathies is a term coined to describe an umbrella of disorders characterized by abnormal Tau polypeptide deposits in neurons, glial cells, and extracellular space. In this work, we propose a novel quantification protocol for the study of tauopathies based on the U-Net neural netwo...

Descripción completa

Detalles Bibliográficos
Autores principales: Campero-Garcia, Luis A., Cantoral-Ceballos, Jose A., Martinez-Maldonado, Alejandra, Luna-Muñoz, Jose, Ontiveros-Torres, Miguel A., Gutierrez-Rodriguez, Andres E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404816/
https://www.ncbi.nlm.nih.gov/pubmed/36009757
http://dx.doi.org/10.3390/biology11081131
_version_ 1784773727043452928
author Campero-Garcia, Luis A.
Cantoral-Ceballos, Jose A.
Martinez-Maldonado, Alejandra
Luna-Muñoz, Jose
Ontiveros-Torres, Miguel A.
Gutierrez-Rodriguez, Andres E.
author_facet Campero-Garcia, Luis A.
Cantoral-Ceballos, Jose A.
Martinez-Maldonado, Alejandra
Luna-Muñoz, Jose
Ontiveros-Torres, Miguel A.
Gutierrez-Rodriguez, Andres E.
author_sort Campero-Garcia, Luis A.
collection PubMed
description SIMPLE SUMMARY: Tauopathies is a term coined to describe an umbrella of disorders characterized by abnormal Tau polypeptide deposits in neurons, glial cells, and extracellular space. In this work, we propose a novel quantification protocol for the study of tauopathies based on the U-Net neural network architecture. We also compare the proposed method against other state of the art variations of the U-Net to test its efficacy. ABSTRACT: Efforts have been made to diagnose and predict the course of different neurodegenerative diseases through various imaging techniques. Particularly tauopathies, where the tau polypeptide is a key participant in molecular pathogenesis, have significantly increased their morbidity and mortality in the human population over the years. However, the standard approach to exploring the phenomenon of neurodegeneration in tauopathies has not been directed at understanding the molecular mechanism that causes the aberrant polymeric and fibrillar behavior of the tau protein, which forms neurofibrillary tangles that replace neuronal populations in the hippocampal and cortical regions. The main objective of this work is to implement a novel quantification protocol for different biomarkers based on pathological post-translational modifications undergone by tau in the brains of patients with tauopathies. The quantification protocol consists of an adaptation of the U-Net neural network architecture. We used the resulting segmentation masks for the quantification of combined fluorescent signals of the different molecular changes tau underwent in neurofibrillary tangles. The quantification considers the neurofibrillary tangles as an individual study structure separated from the rest of the quadrant present in the images. This allows us to detect unconventional interaction signals between the different biomarkers. Our algorithm provides information that will be fundamental to understanding the pathogenesis of dementias with another computational analysis approach in subsequent studies.
format Online
Article
Text
id pubmed-9404816
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94048162022-08-26 A Novel Automatic Quantification Protocol for Biomarkers of Tauopathies in the Hippocampus and Entorhinal Cortex of Post-Mortem Samples Using an Extended Semi-Siamese U-Net Campero-Garcia, Luis A. Cantoral-Ceballos, Jose A. Martinez-Maldonado, Alejandra Luna-Muñoz, Jose Ontiveros-Torres, Miguel A. Gutierrez-Rodriguez, Andres E. Biology (Basel) Article SIMPLE SUMMARY: Tauopathies is a term coined to describe an umbrella of disorders characterized by abnormal Tau polypeptide deposits in neurons, glial cells, and extracellular space. In this work, we propose a novel quantification protocol for the study of tauopathies based on the U-Net neural network architecture. We also compare the proposed method against other state of the art variations of the U-Net to test its efficacy. ABSTRACT: Efforts have been made to diagnose and predict the course of different neurodegenerative diseases through various imaging techniques. Particularly tauopathies, where the tau polypeptide is a key participant in molecular pathogenesis, have significantly increased their morbidity and mortality in the human population over the years. However, the standard approach to exploring the phenomenon of neurodegeneration in tauopathies has not been directed at understanding the molecular mechanism that causes the aberrant polymeric and fibrillar behavior of the tau protein, which forms neurofibrillary tangles that replace neuronal populations in the hippocampal and cortical regions. The main objective of this work is to implement a novel quantification protocol for different biomarkers based on pathological post-translational modifications undergone by tau in the brains of patients with tauopathies. The quantification protocol consists of an adaptation of the U-Net neural network architecture. We used the resulting segmentation masks for the quantification of combined fluorescent signals of the different molecular changes tau underwent in neurofibrillary tangles. The quantification considers the neurofibrillary tangles as an individual study structure separated from the rest of the quadrant present in the images. This allows us to detect unconventional interaction signals between the different biomarkers. Our algorithm provides information that will be fundamental to understanding the pathogenesis of dementias with another computational analysis approach in subsequent studies. MDPI 2022-07-28 /pmc/articles/PMC9404816/ /pubmed/36009757 http://dx.doi.org/10.3390/biology11081131 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Campero-Garcia, Luis A.
Cantoral-Ceballos, Jose A.
Martinez-Maldonado, Alejandra
Luna-Muñoz, Jose
Ontiveros-Torres, Miguel A.
Gutierrez-Rodriguez, Andres E.
A Novel Automatic Quantification Protocol for Biomarkers of Tauopathies in the Hippocampus and Entorhinal Cortex of Post-Mortem Samples Using an Extended Semi-Siamese U-Net
title A Novel Automatic Quantification Protocol for Biomarkers of Tauopathies in the Hippocampus and Entorhinal Cortex of Post-Mortem Samples Using an Extended Semi-Siamese U-Net
title_full A Novel Automatic Quantification Protocol for Biomarkers of Tauopathies in the Hippocampus and Entorhinal Cortex of Post-Mortem Samples Using an Extended Semi-Siamese U-Net
title_fullStr A Novel Automatic Quantification Protocol for Biomarkers of Tauopathies in the Hippocampus and Entorhinal Cortex of Post-Mortem Samples Using an Extended Semi-Siamese U-Net
title_full_unstemmed A Novel Automatic Quantification Protocol for Biomarkers of Tauopathies in the Hippocampus and Entorhinal Cortex of Post-Mortem Samples Using an Extended Semi-Siamese U-Net
title_short A Novel Automatic Quantification Protocol for Biomarkers of Tauopathies in the Hippocampus and Entorhinal Cortex of Post-Mortem Samples Using an Extended Semi-Siamese U-Net
title_sort novel automatic quantification protocol for biomarkers of tauopathies in the hippocampus and entorhinal cortex of post-mortem samples using an extended semi-siamese u-net
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404816/
https://www.ncbi.nlm.nih.gov/pubmed/36009757
http://dx.doi.org/10.3390/biology11081131
work_keys_str_mv AT camperogarcialuisa anovelautomaticquantificationprotocolforbiomarkersoftauopathiesinthehippocampusandentorhinalcortexofpostmortemsamplesusinganextendedsemisiameseunet
AT cantoralceballosjosea anovelautomaticquantificationprotocolforbiomarkersoftauopathiesinthehippocampusandentorhinalcortexofpostmortemsamplesusinganextendedsemisiameseunet
AT martinezmaldonadoalejandra anovelautomaticquantificationprotocolforbiomarkersoftauopathiesinthehippocampusandentorhinalcortexofpostmortemsamplesusinganextendedsemisiameseunet
AT lunamunozjose anovelautomaticquantificationprotocolforbiomarkersoftauopathiesinthehippocampusandentorhinalcortexofpostmortemsamplesusinganextendedsemisiameseunet
AT ontiverostorresmiguela anovelautomaticquantificationprotocolforbiomarkersoftauopathiesinthehippocampusandentorhinalcortexofpostmortemsamplesusinganextendedsemisiameseunet
AT gutierrezrodriguezandrese anovelautomaticquantificationprotocolforbiomarkersoftauopathiesinthehippocampusandentorhinalcortexofpostmortemsamplesusinganextendedsemisiameseunet
AT camperogarcialuisa novelautomaticquantificationprotocolforbiomarkersoftauopathiesinthehippocampusandentorhinalcortexofpostmortemsamplesusinganextendedsemisiameseunet
AT cantoralceballosjosea novelautomaticquantificationprotocolforbiomarkersoftauopathiesinthehippocampusandentorhinalcortexofpostmortemsamplesusinganextendedsemisiameseunet
AT martinezmaldonadoalejandra novelautomaticquantificationprotocolforbiomarkersoftauopathiesinthehippocampusandentorhinalcortexofpostmortemsamplesusinganextendedsemisiameseunet
AT lunamunozjose novelautomaticquantificationprotocolforbiomarkersoftauopathiesinthehippocampusandentorhinalcortexofpostmortemsamplesusinganextendedsemisiameseunet
AT ontiverostorresmiguela novelautomaticquantificationprotocolforbiomarkersoftauopathiesinthehippocampusandentorhinalcortexofpostmortemsamplesusinganextendedsemisiameseunet
AT gutierrezrodriguezandrese novelautomaticquantificationprotocolforbiomarkersoftauopathiesinthehippocampusandentorhinalcortexofpostmortemsamplesusinganextendedsemisiameseunet